Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Kensuke Kume

Department of rheumatology, Hiroshima Clinic, Hiroshima, Japan

Biography

Dr.Kensuke Kume is a chief in Rheumatology and Immunology at Hiroshima Clinic. He is also a member of American college of rheumatology, Asia panpacific league of rheumatology, Japan apheresis and cardio vascuology association. Dr. Kume research interests focus on statistics, rheumatology, autoimmune disease, biologics, and cardiology, and atherosclerosis. His awards includes APLAR Young Investigated Award, Hiroshima medical Award.
Publications

Tocilizumab Improves Arterial Stiffness As Well As Other Biologics with Methotrexate-Resistant Active Rheumatoid Arthritis-An Open Label, Randomized Cohort Multi Center Study

Objectives: To compare the effects of tocilizumab (TCZ) plus methotrexate (MTX), etanercept (ETN) plus MTX, and infliximab (IFX) plus MTX, respectively on arterial stiffness in rheumatoid arthritis (RA) patients despite MTX treatment, in an open-label, randomized study. Methods: 62 RA patients with moderate to severe active disease despite MTX tre... Read More»

Kensuke Kume, Kanzo Amano, Susumu Yamada, Kazuhiko Hatta, Kuniki Amano, Hiroyuki Ohta and Noriko Kuwaba

Research Article: OMICS J Radiol 2015, 4: 186

DOI: 10.4172/2167-7964.1000186

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF

Top